1 ing higher doses initially, and intermittent pulse therapy.

2 py when inadequate responses are seen, or by pulse therapy.

3 roaches such as high-dose methylprednisolone pulse therapy are used to provide transient reductions i

4                                      Steroid pulse therapy followed by PSL 45 mg and immunosuppressiv

5  investigated the effect of cyclophosphamide pulse therapy in sensitized cardiac allograft recipients

6 gned a regimen consisting of intermittent or pulse therapy in which butyrate was administered for 4 d

7 tment of cancer patients with 17-DMAG-based "pulse" therapy may improve the antitumor efficacy of CD8

8                                Dexamethasone pulse therapy reduced but did not eliminate the histolog

9 ts treated with intravenous cyclophosphamide pulse therapy together with intravenous immune globulin

10  the time of transplant; those given steroid pulse therapy were at exceptionally high-risk.

11                                              Pulse therapy with anti-CD3 plus anti-TNF was found to i

12  < 0.001) that were significantly reduced by pulse therapy with dexamethasone for 2 days prior to ani

13                                 Intermittent pulse therapy with low doses of select COX-2 inhibitors